Does Dr. JASMINE AWAD have financial conflicts of interest?

Dr. JASMINE AWAD (CPNP) has received a total of $1,505 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,505 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JASMINE AWAD?

According to CMS Open Payments data, Dr. JASMINE AWAD received funding from SUPERNUS PHARMACEUTICALS ($555), CORIUM ($359), and IRONSHORE PHARMACEUTICALS ($207).

Does Dr. JASMINE AWAD receive research grants or speaking fees?

Dr. JASMINE AWAD has received $1,505 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JASMINE AWAD

CPNPReal-Time Hydrated

Specialty: Nurse Practitioner, Pediatrics

Practice Location: MIDLOTHIAN, VA 23112

NPI Number: 1174250062

LIFETIME INDUSTRY VALUE

$1,505

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AWAD is a verified Nurse Practitioner, Pediatrics practitioner based in MIDLOTHIAN, VA.

Between 2021 and 2024, Dr. AWAD had an overall industry promotional and research financial footprint of $1,505 as recorded in the federal CMS Open Payments database.

$1,505 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AWAD's primary funding source is SUPERNUS PHARMACEUTICALS, which accounts for $555 (representing 36.9% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SUPERNUS PHARMACEUTICALS

Rank 1

$555

36.9%

CORIUM

Rank 2

$359

23.9%

IRONSHORE PHARMACEUTICALS

Rank 3

$207

13.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.